2011 Fiscal Year Final Research Report
Trial to the therapeutic strategy for inflammatory disorders by targeting immunomodulatory molecule OX40 ligand
| Project/Area Number |
21591289
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
膠原病・アレルギー・感染症内科学
|
|---|
| Research Institution | Kansai Medical University |
|---|
Principal Investigator |
ITO Tomoki 関西医科大学, 医学部, 准教授 (70434826)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
INABA Muneo 関西医科大学, 医学部, 非常勤講師 (70115947)
FUKUHARA Shirou 関西医科大学, 医学部, 教授 (40142301)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | 臨床免疫学 |
|---|
| Research Abstract |
We found that OX40L plays an important role in the allergic inflammation by which IL-33 mediates Th2 cell differentiation. Moreover, OX40L was found to inhibit the induction of FOXP3 and CTLA4 in the generation of regulatory T cells. We also found that statins have capacity to inhibit the DC-derived OX40L induction.
|
